Rheumnow Podcast

879 Episodes

1. JAK Inhibitors for New Indications

   Published: 6/13/2024
2. Transition from Psoriasis to PsA: Can we Prevent It?

   Published: 6/13/2024
3. EULAR 2024 Daily Recap - Days 1 & 2

   Published: 6/13/2024
4. Mechanistic Promise in RA Doesn’t Always Mean Actual Gain

   Published: 6/13/2024
5. The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis

   Published: 6/13/2024
6. Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?

   Published: 6/13/2024
7. Voclosporin and Steroids in Lupus Nephritis

   Published: 6/13/2024
8. 3 Big Lupus Themes from EULAR 2024

   Published: 6/13/2024
9. Does B Cell Depletion Matter?

   Published: 6/13/2024
10. Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?

    Published: 6/13/2024
11. Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?

    Published: 6/13/2024
12. Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?

    Published: 6/13/2024
13. Is Cannabis Safe? (6.7.2024)

    Published: 6/7/2024
14. ACR’s Run at Goliath (PCPs) (5.31.2024)

    Published: 5/31/2024
15. The Window of Opportunity (5.24.2024)

    Published: 5/24/2024
16. Don't You Know Who I am (5.17.2024)

    Published: 5/17/2024
17. My Cancelled Lecture (5.11.2024)

    Published: 5/11/2024
18. Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs

    Published: 5/8/2024
19. Featured BSR Abstracts (5.3.2024)

    Published: 5/3/2024
20. SLE Faculty Panel Q&A - Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush

    Published: 5/2/2024